Literature DB >> 9648355

Prognostic scores for use in African meningococcal epidemics.

E K Ajayi-Obe1, E Lodi, A S Alkali, M Galbati, C Rooney, B Mannoni, P Grim, A Nasidi, I Mohammed.   

Abstract

Current WHO guidelines for the case management of meningococcal infections during epidemics in developing countries often cannot be applied, largely because of the limited health resources in such countries. Several scoring scales based on clinical and laboratory features in numerous combinations have been developed for the management of meningococcal infections in developed countries, and these have facilitated early identification of patients with fulminant disease and thus early intervention and reduction in mortality. Unfortunately such scoring scales are not appropriate for use in developing countries. We identified hypotension, tachycardia, tachypnoea, delay in capillary refill time, coma, absence of neck stiffness and petechiae and/or purpura as simple prognostic factors of meningococcal disease. Two scores were developed: score I, which includes all seven prognostic factors, had a sensitivity and specificity of 80% and 94%, respectively. Score II, which excluded hypotension, had a sensitivity and specificity of 73.3% and 89.7%, respectively. Quick and simple scoring scales are therefore not only applicable but useful for the case management of patients in meningococcal epidemics in developing countries.

Entities:  

Mesh:

Year:  1998        PMID: 9648355      PMCID: PMC2305646     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  9 in total

1.  The epidemic of cerebrospinal fever in the northern provinces of Nigeria, 1949-1950.

Authors:  D W HORN
Journal:  J R Sanit Inst       Date:  1951-09

2.  Pediatric coma scale.

Authors:  D Simpson; P Reilly
Journal:  Lancet       Date:  1982-08-21       Impact factor: 79.321

3.  An epidemic of meningococcal infection at Zaria, Northern Nigeria. 1. General epidemiological features.

Authors:  B M Greenwood; A K Bradley; P G Cleland; M H Haggie; M Hassan-King; L S Lewis; J T Macfarlane; A Taqi; H C Whittle; A M Bradley-Moore; Q Ansari
Journal:  Trans R Soc Trop Med Hyg       Date:  1979       Impact factor: 2.184

4.  Prognostic Factors in meningococcal disease.

Authors:  P M Niklasson; P Lundbergh; T Strandell
Journal:  Scand J Infect Dis       Date:  1971

5.  Factors in the prognosis of meningococcal infection. Review of 63 cases with emphasis on recognition and management of the severely ill patient.

Authors:  E R Stiehm; D S Damrosch
Journal:  J Pediatr       Date:  1966-03       Impact factor: 4.406

6.  Epidemic of meningococcal meningitis in Bamako, Mali: epidemiological features and analysis of vaccine efficacy.

Authors:  N Binkin; J Band
Journal:  Lancet       Date:  1982-08-07       Impact factor: 79.321

7.  Prognostic factors in acute meningococcaemia.

Authors:  L S Lewis
Journal:  Arch Dis Child       Date:  1979-01       Impact factor: 3.791

8.  Validation of the Glasgow Meningococcal Septicemia Prognostic Score: a 10-year retrospective survey.

Authors:  A P Thomson; J A Sills; C A Hart
Journal:  Crit Care Med       Date:  1991-01       Impact factor: 7.598

9.  Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children.

Authors:  M E Molyneux; T E Taylor; J J Wirima; A Borgstein
Journal:  Q J Med       Date:  1989-05
  9 in total
  3 in total

1.  Diagnosing and treating attentional difficulties: a nationwide survey.

Authors:  I McKenzie; C Wurr
Journal:  Arch Dis Child       Date:  2004-10       Impact factor: 3.791

2.  Capillary refill: prognostic value in Kenyan children.

Authors:  A Pamba; K Maitland
Journal:  Arch Dis Child       Date:  2004-10       Impact factor: 3.791

3.  Prediction of Outcome From Adult Bacterial Meningitis in a High-HIV-Seroprevalence, Resource-Poor Setting Using the Malawi Adult Meningitis Score (MAMS).

Authors:  Emma C Wall; Mavuto Mukaka; Matthew Scarborough; Katherine M A Ajdukiewicz; Katharine E Cartwright; Mulinda Nyirenda; Brigitte Denis; Theresa J Allain; Brian Faragher; David G Lalloo; Robert S Heyderman
Journal:  Clin Infect Dis       Date:  2017-02-15       Impact factor: 9.079

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.